InnoCon Medical ApS: Financial statements 2019
CVR: 38635794
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
InnoCon Medical ApS (CVR 38635794) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -318,578 and a net result of DKK -242,973 compared with DKK -253,823 the year before. Equity in the 2019 report amounted to DKK 6,048,444. The solvency ratio was 42.5%. The company had 6 employees in the financial year.
- Gross Profit
- DKK -318,578
- Profit/Loss
- DKK -242,973
- Equity
- DKK 6,048,444
- Total Assets
- DKK 14,224,558
- Employees
- 6
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -319 t. | -243 t. | 6 mio. | 6 |
| 2018 | - | -333 t. | -254 t. | 6.3 mio. | 4 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of December 4, 2019, Ulrik Spork has joined the board of directors of InnoCon Medical ApS.
As of December 4, 2019, Frank Blömer has left the board of directors of InnoCon Medical ApS.
InnoCon Medical ApS has published its annual report for 2018. Gross profit came to DKK -333,077, and the net result was DKK -253,823.
About InnoCon Medical ApS
InnoCon Medical ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2017. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Jesper Nielsen. The board consists of Ulrik Spork (chair), Axel Nørskov Laursen, Jens Lübeck Johansen and Ulrik Jespersen. The company's owners include Blokhus Invest ApS, NORLAU ApS and JLJ BUSINESS DEVELOPMENT ApS. The company has 12 employees (2026). In 2025, the company reported a gross profit of DKK 6,226,227 and a net result of DKK -206,376 compared with DKK 173,088 the year before. Equity in the 2025 report amounted to DKK 50,108,166.